摘要
目的探讨参麦注射液配合常规疗法治疗慢性阻塞性肺病(COPD)急性发作的疗效及其对红细胞免疫功能的影响。方法将80例COPD急性发作期患者随机分为常规疗法组和联用参麦治疗组,联用参麦治疗组在常规疗法的基础上联用参麦注射液治疗。观察两组红细胞免疫功能的变化。结果联用参麦治疗组治疗后C3bRR、RFER较对照组升高明显,而ICR and RFIR明显低于对照组。结论在常规疗法的基础上联用参麦注射液治疗COPD急性发作能改善红细胞免疫功能。
Objective To investigate the effect of shenmai injection（SMI）on patients of AECOPD.Methods 80 patients were divided into two groups,the control group treated with conventional medicine and the therapy group treated with conventional medicine plus SMI.The indices including red blood cell C3bRR、RFER、ICR and RFIR.Results The level of C3bRR、RFER in therapy group is higher than control group,The level of ICR and RFIR in therapy group is lower than control group.Conclusion SMI has the effecting regulating immune functon in patients with COPD.
出处
《四川医学》
CAS
2010年第8期1040-1041,共2页
Sichuan Medical Journal
基金
四川省卫生厅科研资助项目(编号:303.005.002.178.003)
